Browse > Article

Increase in Intracellular Calcium is Necessary for RANKL Induction by High Extracellular Calcium  

Jun, Ji-Hae (Department of Pharmacology and Dental Therapeutics, College of Dentistry, Dental Research Institute, Seoul National University)
Kim, Hyung-Keun (Department of Pharmacology and Dental Therapeutics, College of Dentistry, Dental Research Institute, Seoul National University)
Woo, Kyung-Mi (Department of Pharmacology and Dental Therapeutics, College of Dentistry, Dental Research Institute, Seoul National University)
Kim, Gwan-Shik (Department of Pharmacology and Dental Therapeutics, College of Dentistry, Dental Research Institute, Seoul National University)
Baek, Jeong-Hwa (Department of Pharmacology and Dental Therapeutics, College of Dentistry, Dental Research Institute, Seoul National University)
Publication Information
International Journal of Oral Biology / v.30, no.1, 2005 , pp. 9-15 More about this Journal
Abstract
Recently, we reported that high extracellular calcium increased receptor activator of nuclear factor-${\kappa}B$ ligand (RANKL) expression via p44/42 mitogen-activated protein kinase (p44/42 MAPK) activation in mouse osteoblasts. However, the mechanism for p44/42 MAPK activation by high extracellular calcium is unclear. In this study, we examined the role of intracellular calcium increase in high extracellular calcium-induced RANKL induction and p44/42 MAPK activation. Primary cultured mouse calvarial osteoblasts were used. RANKL expression was highly induced by 10 mM calcium treatment. Ionomycin, a calcium ionophore, also increased RANKL expression and activated p44/42 MAPK. U0126, an inhibitor of MEK1/2, an upstream activator of p44/42 MAPK, blocked the RANKL induction by both high extracellular calcium and ionomycin. High extracellular calcium increased the phosphorylation of proline-rich tyrosine kinase 2 (Pyk2), one of the known upstream regulators of p44/42 MAPK activation. Bisindolylmaleimide, an inhibitor of protein kinase C, did not block RANKL induction and p44/42 MAPK activation induced by high extracellular calcium. 2-Aminoethoxydiphenyl borate, an inhibitor of inositol 1,4,5-trisphosphate (IP3) receptor, blocked the RANKL induction by high extracellular calcium. It also partially suppressed the activation of Pyk2 and p44/42 MAPK. Cyclosporin A, an inhibitor of calcineurin, also inhibited high calcium-induced RANKL expression in dose dependent manner. However, cyclosporin A did not affect the activation of Pyk2 and p44/42 MAPK by high extracellular calcium treatment. These results suggest that 1) the increase in intracellular calcium via IP3-mediated calcium release is necessary for RANKL induction by high extracellular calcium treatment, 2) Pyk2 activation, but not protein kinase C, following the increase in intracellular calcium might be involved in p44/42 MAPK activation, and 3) calcineurin-NFAT activation by the increase in intracellular calcium is involved in RANKL induction by high extracellular calcium treatment.
Keywords
High extracellular calcium; RANKL; p44/42 MAPK; Intracellular calcium; Pyk2; Calcineurin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Kifor, O., MacLeod, R.J., Diaz, R., Bai, M., Yamaguchi, T., Yao, T., Kifor, I. and Brown, E.M.: Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am. J. Physiol. Renal Physiol. 280:F291-F302, 2001   DOI
2 Kim, Y.H., Pang, S.J., Jun, J.H., Baek, J.H. and Kim, G.S.: The role of p44/42 MAPK activation in $Ca^{2+}$/PKC-induced RANKL expression. Kor. J. Oral Anat. 27:55-63, 2003b
3 Suda, T., Takahashi, N. and Martin, T.J.: Modulation of osteoclast differentiation. Endocr. Rev. 13:66-80, 1992
4 Tahara, S., Fukuda, K., Kodama, H., Kato, T, Miyoshi, S. and Ogawa, S.: Potassium channel blocker activates extracellular signal-regulated kinases through Pyk2 and epidermal growth factor receptor in rat cardiomyocytes. J. Am. Coll. Cardiol. 8:1554-1563, 2001   DOI   ScienceOn
5 Takahashi, N., Udagawa, N. and Suda, T.: A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL,regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256:449-455, 1999   DOI   ScienceOn
6 Yano, S., Macleod, R.J., Chattopadhyay, N., Tfelt-Hansen, J., Kifor, O., Butters, R.R. and Brown, E.M.: Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation. Bone 35:664-672, 2004   DOI   ScienceOn
7 Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T.: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U.S.A. 95:3597-3602, 1998   DOI
8 Wetzker, R. and Bohmer, F.D.: Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat. Rev. Mol. Cell. Biol. 4:651-657, 2003   DOI   ScienceOn
9 Yamaguchi, T., Chattopadhyay, N., Kifor, O., Butters, R.R. Jr., Sugimoto, T. and Brown, E.M.: Mouse osteoblastic cell line (MC3T3 - E1) expresses extracellular calcium($Ca^{2+}\;_o$)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J. Bone Miner. Res. 13:1530-1538, 1998b   DOI   ScienceOn
10 Yamaguchi, T, Kifor, O., Chattopadhyay, N. and Brown, E.M.: Expression of extracellular calcium($Ca^{2+}\;_o$)-sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2. Biochem. Biophys. Res. Commun. 243:753- 757, 1998a   DOI   ScienceOn
11 Kameda, T., Mano, H., Yamada, Y., Takai, H., Amizuka, N., Kobori, M., Izumi, N., Kawashima, H., Ozawa, H., Ikeda, K., Kameda, A., Hakeda, Y. and Kumegawa, M.: Calciumsensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem. Biophys. Res. Commun. 245:419-422, 1998   DOI   ScienceOn
12 Matsuzaki, K., Udagawa, N., Takahashi, N., Yamaguchi, K., Yasuda, H., Shima, N., Morinaga, T., Toyama, Y., Yabe, Y., Higashio, K. and Suda, T.: Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem. Biophys. Res. Commun. 246:199-204, 1998   DOI   ScienceOn
13 Nishida, S, Tsubaki, M., Hoshino, M., Namimatsu, A., Uji, H., Yoshioka, S., Tanimori, Y., Yanae, M., Iwaki, M. and Irimajiri, K.: Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2. Biochem. Biophys. Res. Commun. 328:91-97, 2005   DOI   ScienceOn
14 Pi, M., Gamer, S.C., Flannery, P., Spumey, R.F. and Quarles, L.D.: Sensing of extracellular cations in CasR-deficient osteoblasts. Evidence for a novel cation-sensing mechanism. J. Biol. Chem. 275:3256-3263, 2000   DOI   ScienceOn
15 Sakwe, A.M., Larsson, M. and Rask, L.: Involvement of protein kinase C-alpha and -epsilon in extracellular Ca(2+) signalling mediated by the calcium sensing receptor. Exp. Cell. Res. 97:560-573, 2004
16 Takami, M., Takahashi, N., Udagawa, N., Miyaura, C., Suda, K., Woo, J.T, Martin, T.J., Nagai, K. and Suda, T.: Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. Endocrinology 141:4711-4719, 2000   DOI   ScienceOn
17 Roodman, G.D.: Advances in bone biology: the osteoclast. Endocr. Rev. 4:308-332, 1996
18 Boutahar, N., Guignandon, A., Vico, L. and Lafage-Proust, M.H.: Mechanical strain on osteoblasts activates autophosphorylation of focal adhesion kinase and proline-rich tyrosine kinase 2 tyrosine sites involved in ERK activation. J. Biol. Chem. 279:30588-30599, 2004   DOI   ScienceOn
19 Lacey, D.L., Timms, E., Tan, H.L., Kelly, M.J., Dunstan, C.R., Burgess, T., Elliot, R., Colombero, A., Elliot, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y.X., Kaufinan, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J. and Boyl, W.J.: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176, 1998   DOI   ScienceOn
20 Brown, E.M. and MacLeod, R.J.: Extracellular calcium sensing and extracellular calcium signaling. Physiol. Rev. 81:239-297, 2001
21 Tsai, J.A., Bucht, E., Torring, O. and Kindmark, H.: Extracellular calcium increases free cytoplasmic calcium and DNA synthesis in human osteoblasts. Horm. Metab. Res. 6:22-26, 2004
22 Shin, M.M., Kim, Y.H., Kim, S.N., Kim, G.S. and Baek, J.H.: High extracellular $Ca^{2+}$ alone stimulates osteoclast formation but inhibits in the presence of other osteoclastogenic factors. Exp. Mol. Med. 35:167-174, 2003   DOI   ScienceOn
23 Quinn, J.M.W., Elliot, J., Gillespie, M.T. and Martin, T.J.: A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424-4427, 1998   DOI   ScienceOn
24 Yang, T.T., Xiong, Q., Graef, I.A., Crabtree, G.R. and Chow, C.W.: Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex. Mol. Cell. Biol. 25:907-920, 2005   DOI   ScienceOn
25 Hogan, P.G., Chen, L., Nardone, J. and Rao, A.: Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17:2205-2232, 2003   DOI   ScienceOn
26 Hofbauer, L.C., Shui, C., Riggs, B.L., Dunstan, C.R., Spelsberg, T.C., O'Brien, T. and Khosla, S.: Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem. Biophys. Res. Commun. 280:334-339, 2001   DOI   PUBMED   ScienceOn
27 Kim, Y.H., Kim, J.M., Kim, S.N., Kim, G.S. and Baek, J.H.: p44/42 MAPK activation is necessary for receptor activator of nuclear factor-kappaB ligand induction by high extracellular calcium. Biochem. Biophys. Res. Commun. 304:729-735, 2003a   DOI   PUBMED   ScienceOn
28 Sanna, B., Bueno, O.F., Dai, Y.S, Wilkins, B.J. and Molkentin, J.D.: Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Mol. Cell. Biol. 25:865-878, 2005   DOI   ScienceOn